Anja Krammer is the Chief Executive Officer of Turn Biotechnologies, a development stage company focused on reversing aging and age-related diseases. She co-founded, served as President, Secretary and a director of BioPharmX. Ms. Krammer served as Principal/Founder of MBI, Inc., a management consulting firm beginning in January 1998. She holds a BAIS degree with a focus on Marketing/Management from the University of South Carolina and an International Trade Certificate from the University of Paris—Sorbonne.